FFC
vs
S
S&P/ASX 300
FFC
Over the past 12 months, FFC has underperformed S&P/ASX 300, delivering a return of 0% compared to S&P/ASX 300's +2% growth.
Stocks Performance
FFC vs S&P/ASX 300
Performance Gap
FFC vs S&P/ASX 300
Performance By Year
FFC vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Farmaforce Ltd
Glance View
FarmaForce Ltd. engages in the provision of contract sales and marketing services in Australia. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-10-27. The firm also provides scalable, customized solutions on demand to its clients. The firm operates through two segments: contract sales and marketing services to external customers, and services to related parties. The Company’s data intelligence services include market surveys, geo-mapping, market analysis and sales force analytics. The Company’s medical affairs solutions include various services, such as medical science liaisons (MSLs) teams and solutions to meet client’s business goals, medical information service for timely response to product related enquiries, pharmacovigilance operations (PV) that ensure compliance with local PV/ product safety regulations. Its medical affairs product pre-launch planning and implementation focused on client’s product launch needs and readiness.
